TCMBANKIN001263 |
n,n-dimethyltryptamine-methohydroxide |
|
C13H20N2O |
|
C[N+](C)(C)CCC1=CNC2=CC=CC=C21.[OH-] |
TCMBANKIN001609 |
γ-hydroxypalmiticacid lactone |
|
C16H30O2 |
|
|
TCMBANKIN001852 |
cadmium |
|
Cd |
112.41 g/mol |
[Cd] |
TCMBANKIN008171 |
nb-methyltetrahydroharman |
|
C13H16N2 |
|
CC1C2=C(CCN1C)C3=CC=CC=C3N2 |
TCMBANKIN011661 |
n,n-dimethyltryptamine-n-oxide |
n,n-dimethyltryptaminen-oxide; n,n-dimethyltryptamine n-oxide |
C12H16N2O |
204.27 g/mol |
C[N+](C)(CCC1=CNC2=CC=CC=C21)[O-] |
TCMBANKIN018281 |
hovenine A |
hovenine a; AC1NSWCZ; (Z)-N-[(5E,8E,10Z)-5,8-DIHYDROXY-3-ISOPROPYL-7-(2-METHYLPROPYL)-2-OXA-6,9-DIAZABICYCLO[10.2.2]HEXADECA-1(14),5,8,10,12,15-HEXAEN-4-YL]-3-METHYL-2-(METHYLAMINO)PENTANIMIDIC ACID; 3-methyl-2-(methylamino)-N-[(2Z)-6-(2-methylpropyl)-5,8-dioxo-10-propan-2-yl-11-oxa-4,7-diazabicyclo[10.2.2]hexadeca-1(14),2,12,15-tetraen-9-yl]pentanamide; N-Demethylfrangulanine; 3-methyl-2-(methylamino)-N-[7-(2-methylpropyl)-5,8-dioxo-3-(propan-2-yl)-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),10,12,15-tetraen-4-yl]pentanamide; Hovenine A |
C27H42N4O4 |
486.65 |
CCC(C)C(C(=O)NC1C(OC2=CC=C(C=C2)C=CNC(=O)C(NC1=O)CC(C)C)C(C)C)NC |
TCMBANKIN022547 |
n,n-dimethyltryptamine |
EINECS 200-508-4; ZINC897457; MB00483; 2-(1H-Indol-3-yl)-N,N-dimethylethanamine #; AN-41827; Indolalkylamine der; GTPL141; FT-0667348; BRN 0138259; WUB601BHAA; DB01488; 61-50-7; WLN: T56 BMJ D2N1&1; FCH838678; AKOS005446117; STK370594; Dimethyltryptamine(DMT); DTXSID60110053; N,N-Dimethyltryptamine, >=97% (HPLC); 2-(1H-indol-3-yl)-N,N-dimethylethylamine; 3-[2- (dimethylamino)ethyl]-Indole; N,N-dimethyl-1H-Indole-3-ethanamine (9CI); AC1L1LS3; KB-296215; 2-(1H-Indol-3-yl)-N,N-dimethylethanamine; SCHEMBL335710; NSC63795; 061D507; N,N-Dimethyltryptamine, free base; N,N-DIMETHYLTRYPTAMINE; DIMETHYLTRYPTAMINE; 1H-Indole-3-ethanamine, N,N-dimethyl-; N,N-dimethyl-1H-Indole-3-ethanamine; 1H-INDOLE-3-ETHANAMINE,N,N-DIMETHYL; InChI=1/C12H16N2/c1-14(2)8-7-10-9-13-12-6-4-3-5-11(10)12/h3-6,9,13H,7-8H2,1-2H; 3-(2-(dimethylamino)ethyl)-Indole; Indole, 3-[2-(dimethylamino)ethyl]-; D-5500; (2-Indol-3-ylethyl)dimethylamine; LS-82930; 2-(1H-indol-3-yl)-N,N-dimethylethanamine (ACD/Name 4.0); [2-(1H-indol-3-yl)ethyl]dimethylamine; 2-(3-Indolyl)ethyldimethylamine; 2-(1H-INDOL-3-YL)-N,N-DIMETHYL-ETHANAMINE; NSC-63795; CHEMBL12420; DMT (psychogenic); UNII-WUB601BHAA; MFCD00055989; Indole, 3-(2-(dimethylamino)ethyl)-; N,N-Dimethyltryptamine (DMT) solution, 1.0 mg/mL in methanol, certified reference material; D0K1QS; DEA No. 7435; N-(2-(1H-indol-3-yl)ethyl)-N,N-dimethylamine (ACD/Name 4.0); [2-(1H-INDOL-3-YL)-ETHYL]-DIMETHYL-AMINE; CHEBI:28969; BDBM50026868; 2-(1H-indol-3-yl)-ethyl-dimethyl-amine; 1H-Indole-3-ethanamine, N,N-dimethyl- (9CI); 3-[2-(dimethylamino)ethyl]indole; 3-(2-Dimethylaminoethyl)indole; NSC 63795; 3-(2-DIMETHYLAMINOETHYL) INDOLE; L001288; CTK5B3344; DMULVCHRPCFFGV-UHFFFAOYSA-N; 1H-Indole-3-ethanamine,N,N-dimethyl-; C08302; HSDB 8017; 3-(dimethylaminoethyl)-indole; N,N-Dimethyl-1H-indole-3-ethylamine; (psychogenic); 68677-25-8 |
C12H16N2 |
188.27 g/mol |
CN(C)CCC1=CNC2=CC=CC=C21 |
TCMBANKIN032546 |
5-methoxy Nobiletin |
|
|
|
|
TCMBANKIN034593 |
2,4-dione-tridecane |
|
|
|
|
TCMBANKIN035929 |
2-methoxy-3-methyl-9,10-anthraquinone |
2-methoxy-3-methylanthracene-9,10-dione; 2-methoxy-3-methyl-anthracene-9,10-dione |
C16H12O3 |
252.26 g/mol |
CC1=CC2=C(C=C1OC)C(=O)C3=CC=CC=C3C2=O |
TCMBANKIN037542 |
9-Hydroxy-10-,12-pentadecadienoic acid |
9-hydroxy-10,12-pentadecadienoicacid |
C15H26O3 |
254.365 |
C([H])([H])([H])C([H])([H])\C([H])=C([H])\C([H])=C([H])\[C@]([H])(O[H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(=O)O[H] |
TCMBANKIN038837 |
n-methyltyramine |
Methyl-4-tyramine; 370-98-9; N-methyltyraminium cation; C02442; 4-(2-methylaminoethyl)phenol; Phenol, 4-(2-(methylamino)ethyl)- (9CI); A823530; p-(2-(Methylamino)ethyl)phenol; 4-[2-(methylamino)ethyl]phenol; CHEBI:58155; PHENOL, p-(2-METHYLAMINOETHYL)-; N-methyltyraminium; Phenol, p-[2-(methylamino)ethyl]-; BRN 2357129; NMT; N-Methyltyramine; 2-(4-hydroxyphenyl)ethyl-methylammonium; WIN 5582; 2-(4-hydroxyphenyl)ethyl-methyl-azanium; NSC113958; p-[2-(Methylamino)ethyl]phenol; Tyramine, N-methyl-; p-(2-Methylaminoethyl)phenol; EINECS 206-731-3; 4-13-00-01790 (Beilstein Handbook Reference); 4-Hydroxy-N-methylphenethylamine; CHEBI:17458; N-methyltyraminium(1+); NSC 113958; Phenol, 4-[2-(methylamino)ethyl]-; 2-(4-hydroxyphenyl)-N-methylethanaminium |
C9H13NO |
151.21 |
CCC(C)C(=O)N |
TCMBANKIN040823 |
Hypecoumine |
AC1NSWSP; 5-([1,3]dioxolo[4,5-g]isoquinolin-5-yl)-5H-furo[3,4-f][1,3]benzodioxol-7-one |
|
349.3 g/mol |
|
TCMBANKIN046392 |
hypaphorine |
NSC130253; AC1MYRI7; MolPort-001-741-904; HMS2271P06; Hypaphorine, >=95% (LC/MS-ELSD); 3-(1H-indol-3-yl)-2-(trimethylammonio)propanoate; CHEMBL448328; NP-005551; SMR000440569; MCULE-3745207364; MLS000876774; SCHEMBL4736466; NSC-130253; 3-(1H-indol-3-yl)-2-(trimethylazaniumyl)propanoate |
C14H18N2O2 |
246.3 g/mol |
C[N+](C)(C)C(CC1=CNC2=CC=CC=C21)C(=O)[O-] |
TCMBANKIN047879 |
n-methyl tyramine-o-alpha-l-rhamnopyranoside |
N-methyltyramine-O-α-L-rhamnopyranoside; n-methyl tyramine-o-α-l-rhamnopyranoside |
|
297.347 |
CC1C(C(C(C(O1)OC2=CC=C(C=C2)CCNC)O)O)O |
TCMBANKIN049534 |
n-methyltetrahydroharmol |
|
C14H18N2 |
0 |
CC1C2=C(CCN1C)C3=C(N2)C(=CC=C3)C |
TCMBANKIN057899 |
arsenicum;arsenic;as |
|
As |
74.92159 g/mol |
[As] |
TCMBANKIN057904 |
cuprum |
copper |
Cu |
63.55 g/mol |
[Cu] |
TCMBANKIN057906 |
mercury |
hydrargyrum |
Hg |
200.59 g/mol |
[Hg] |
TCMBANKIN057910 |
plumbum |
lead |
Pb |
207 g/mol |
[Pb] |
TCMBANKIN058349 |
phenethylamine |
2-PHENYLETHYLAMINE SULFATE; AC1O4DZ7;PEA;NSC10811; (2-Aminoethyl)polystyrene; 81559_FLUKA; 2-phenylethanamine; Phenethylamine; Benzeneethanamine; Polystyrene A-NH2; Ethanamine, 2-phenyl-; 64-04-0; BRN 0507488; 2-Fenylethylamin [Czech]; .beta.-Phenylaethylamin; 41346_FLUKA; NSC 10811; ST5213756; 4-12-00-02453 (Beilstein Handbook Reference); beta-phenylethylamine; 81558_FLUKA; 1-Phenyl-2-aminoethane; beta-Aminoethylbenzene; Ethylamine, 2-phenyl-; beta-Phenylaethylamin [German]; SMR000471837; NCGC00163366-01; 241008_ALDRICH; 1-Amino-2-phenylethane; EINECS 200-574-4; 2-phenylethylamine; AI3-03117; W322008_ALDRICH; PHENETHYLAMINE, BETA; InChI=1/C8H11N/c9-7-6-8-4-2-1-3-5-8/h1-5H,6-7,9H; AIDS-018561; PHENYLETHYLAMINE; .omega.-Phenylethylamine; C05332; .beta.-Phenethylamine; 2-Phenethylamine; CHEBI:18397; 1-Phenyl-2-amino-athan; FEMA No. 3220; AIDS018561; beta-Phenethylamine; .beta.-Aminoethylbenzene; .beta.-Phenylethylamine; WLN: Z2R; 1-Phenyl-2-amino-athan [German]; HSDB 3526; MLS001066395; 128945_ALDRICH; 2-Amin |
C8H11N |
121.18 g/mol |
C1=CC=C(C=C1)CCN |
TCMBANKIN058352 |
phenethyl caffeate |
ZINC7996909; (Z)-3-(3,4-Dihydroxyphenyl)propenoic acid 2-phenylethyl ester; AC1O7G1P; 132336-00-6; Lopac-C-8221; CHEMBL1397711; NCGC00015274-01; phenethyl (Z)-3-(3,4-dihydroxyphenyl)prop-2-enoate; MolPort-009-018-747 |
C17H16O4 |
284.31 g/mol |
C1=CC=C(C=C1)CCOC(=O)C=CC2=CC(=C(C=C2)O)O |
TCMBANKIN058681 |
1,1-Dimethyl-2-(3-methyl-1,3-butadiene)-cyclo-propane |
1,1-dimethyl-2-(3-methyl-1,3-butadiene)-cyclo-propane; 1,1-dimethyl-2(3-methyl-1,3-butadienyl)-cyclopropane |
C10H16 |
136.26 |
CC(=C)C=CC1CC1(C)C |
TCMBANKIN061289 |
hordenine |
|
C10H15NO |
165.23g/mol |
CN(C)CCC1=CC=C(C=C1)O |
TCMBANKIN061290 |
MeODMT;n,n-dimethyl-5-methoxy tryptamine |
|
C13H18N2O |
218.29 |
CN(C)CCC1=CNC2=C1C=C(C=C2)OC |